25-OR: ADA Presidents' Select Abstract: Preclinical Evaluation of TYK2 Inhibitors in Type 1 Diabetes
FAROOQ SYED(Indianapolis Zoo), Carmella Evans‐Molina(Richard L. Roudebush VA Medical Center), Kara S. Orr(Indiana University – Purdue University Indianapolis), Maria Inês Alvelos(Université Libre de Bruxelles), Ângela Castela(Université Libre de Bruxelles), Alexandra Coomans de Brachène(Université Libre de Bruxelles), Arnaud Zaldumbide(Leiden University Medical Center), Staci A. Weaver(Indianapolis Zoo), Sofia Thomaidou, DECIO L. EIZIRIK(Indianapolis Zoo), Donalyn Scheuner(Indiana Biosciences Research Institute), Garrick Chang(Indiana University Indianapolis), Jyoti Rana(Indiana University – Purdue University Indianapolis), Olivia Ballew(Indiana Biosciences Research Institute), Jing Liu(Purdue University West Lafayette), Stéphane Demine(Indiana Biosciences Research Institute), Chih‐Chun Lee(Diabetes Australia), KENTARO YAMADA(Indianapolis Zoo)
Cited by 1
Related Papers
Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in <i>db/db</i> Mice
|Diabetes|2018|385
Inhibiting glycogen synthesis prevents lafora disease in a mouse model
|Annals of Neurology|2013|111
The praxis of acknowledgement: from bibliometrics to influmetrics
|Revista española de Documentación Científica|1995|77
Profiling of RNAs from Human Islet-Derived Exosomes in a Model of Type 1 Diabetes
|International Journal of Molecular Sciences|2019|60
Brain glycogen supercompensation in the mouse after recovery from insulin‐induced hypoglycemia
|Journal of Neuroscience Research|2011|47